Bridging the bench-to-bedside gap and promoting multidisciplinarity are pivotal to advancing research and improving patient treatment and care. The implementation and measurable outcomes of both ideals in everyday practice generally translate into increased dialogue and [more]
Gynaecologists don’t win top awards at ASCO. German oncologists don’t make it on the international stage. Women who want large families can’t expect to be leaders in their field. Nadia Harbeck’s high-flying career and relaxed [more]
The traditional approach to managing locally advanced rectal cancer has shifted to the concept of total mesorectal excision and the use of MRI for local staging and selecting patients for multimodal therapy. This case report [more]
Allegations that commercial pressures may be leading to cancer drug trials being halted prematurely hit the news on both sides of the Atlantic last April. Industry leaders are pleading not guilty’. But how can we [more]
Cornelis van de Velde went into cancer because he loved the complexity. Throughout his career he has grasped each new development across the disciplines to see how it could help resolve the difficult balance between [more]
Surgery still offers by far the best hope of a cure in solid tumours. Yet patients are being let down by too great a focus on drugs at the expense of investment in surgical equipment [more]
Though the role of radiation therapy in the adjuvant treatment of pancreatic cancer remains controversial, a recent large retrospective study indicates that radiation is associated with improved survival. Download full article
Two recent studies have shown that lenalidomide in combination with high-dose dexamethasone is significantly more effective than high-dose dexamethasone alone in patients with relapsed multiple myeloma. Download full article
A rising focus on men’s health issues, more sophisticated registry data and new techniques for investigating the biology of cancers are fuelling interest in unravelling what lies behind gender differences in cancer incidence and mortality. [more]
Evidence from a growing number of robust studies points incontrovertibly towards the benefits of regular, moderate activity not just in preventing cancer, but in rehabilitation for survivors and protection against recurrence. The question, as ever, [more]